Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Sell
181,182
-124,385
-41% -$1.34M ﹤0.01% 5849
2026
Q1
$2.59M Buy
305,567
+292,479
+2,235% +$3.2M ﹤0.01% 5594
2025
Q4
$148K Sell
13,088
-556,455
-98% -$6.89M ﹤0.01% 11186
2025
Q3
$8.55M Buy
569,543
+311,666
+121% +$4.54M ﹤0.01% 3249
2025
Q2
$3.64M Buy
257,877
+99,834
+63% +$1.78M ﹤0.01% 4580
2025
Q1
$3.8M Buy
158,043
+109,084
+223% +$3.85M ﹤0.01% 4177
2024
Q4
$1.83M Sell
48,959
-87,062
-64% -$4.06M ﹤0.01% 5520
2024
Q3
$6.8M Sell
136,021
-63,154
-32% -$2.46M ﹤0.01% 3126
2024
Q2
$6.91M Sell
199,175
-1,111
-0.6% -$43.9K ﹤0.01% 2950
2024
Q1
$11M Buy
200,286
+162,210
+426% +$8.03M ﹤0.01% 2481
2023
Q4
$1.63M Sell
38,076
-63,496
-63% -$1.97M ﹤0.01% 5805
2023
Q3
$2.64M Buy
101,572
+7,418
+8% +$154K ﹤0.01% 4611
2023
Q2
$2.25M Sell
94,154
-42,587
-31% -$733K ﹤0.01% 4914
2023
Q1
$1.87M Buy
136,741
+110,992
+431% +$1.77M ﹤0.01% 5284
2022
Q4
$357K Buy
+25,749
New +$364K ﹤0.01% 8674

Other funds holding BHVN

Jeff Yass's BHVN Position: Q2 2026 in Review

Jeff Yass reduced its Biohaven (BHVN) stake by 41% in Q2 2026, selling an estimated $1.34M and leaving 181,182 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #5849.

Jeff Yass first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $11M in Q1 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Jeff Yass held 181,182 shares of Biohaven worth $2.7M as of Q2 2026.
  • Jeff Yass sold 124,385 Biohaven shares in Q2 2026, an estimated $1.34M.
  • Biohaven made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5849 holding.
  • Jeff Yass first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Jeff Yass's Biohaven position peaked at $11M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.